# FDA recall D-1382-2012

> **Hospira, Inc.** · Class II · drug recall initiated 2012-04-11.

## Product

Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.

## Reason for recall

Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel

## Distribution

Nationwide.

## Key facts

- **Recall number:** D-1382-2012
- **Recalling firm:** Hospira, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-04-11
- **Report date:** 2012-06-20
- **Termination date:** 2013-06-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1382-2012

## Citation

> AI Analytics. FDA recall D-1382-2012. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-1382-2012. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*